Abstract
Orexin has been emerged as a hot and frontier research theme in the close relationship with sleep-wake regulation. In this paper, we report a synthetic method for the preparation of 5-methyl-2- (pyrimidin-2-yl)benzoic acid, which is an important molecular fragment of orexin Filorexant (MK- 6096). Compared to the previously reported methods, the current route has the advantages of a short synthetic pathway, simple post-treatment, and high yield that provide an effective new methodology for the synthesis of the target compound. Using 2-bromo-5-methyl benzoic acid and 2- chloropyrimidine as raw materials, PdCl2(PPh3)2 is used as a metal catalyst to mediate one-pot generation of 5-methyl-2-(pyrimidin-2-yl)benzoic acid using the Negishi cross-coupling method. The optimum condition involves 2-bromo-5-methylbenzoic acid (10.00 g) and anhydrous zinc chloride powder (6.32 g) together with the catalyst: 2-bromo-5-methylbenzoic acid molar ratio of 0.02 and 2- chloropyrimidine: 2-bromo-5-methylbenzoic acid molar ratio of 1.1:1 at a reaction temperature of 55°C for 14 h. Under these optimum reaction conditions, the maximum yield of 78.4% is attained for 5- methyl-2-(pyrimidin-2-yl) benzoic acid.
Keywords: 5-methyl-2-(pyrimidin-2-yl) benzoic acid, synthesis, palladium catalysis, negishi, cross-coupling, anhydrous zinc chloride.
Graphical Abstract
[http://dx.doi.org/10.1053/smrv.2002.0186] [PMID: 12531146]
[http://dx.doi.org/10.5664/jcsm.27286] [PMID: 18853708]
[http://dx.doi.org/10.1016/j.smrv.2010.01.003] [PMID: 20359916]
[http://dx.doi.org/10.3109/01677063.2011.566953] [PMID: 21473737]
[http://dx.doi.org/10.1016/S0092-8674(00)80949-6] [PMID: 9491897]
[http://dx.doi.org/10.1016/j.cellsig.2013.07.025] [PMID: 23917208]
[http://dx.doi.org/10.1016/j.neuropharm.2011.10.003] [PMID: 22019562]
[http://dx.doi.org/10.1016/S0092-8674(00)81965-0] [PMID: 10458611]
[http://dx.doi.org/10.1021/op3002678]
[http://dx.doi.org/10.1021/ol5028249] [PMID: 25365229]